Changing from bevacizumab to ranibizumab in age-related macular degeneration. Is it safe?

Changing from bevacizumab to ranibizumab in age-related macular degeneration. Is it safe?

Dimitrios A Karagiannis1, Ioannis D Ladas2, Efstratios Parikakis1, Ilias Georgalas2, Athanasios Kotsolis2, Giorgos Amariotakis1, Vasileios Soumplis1, Panagiotis Mitropoulos11Ophthalmiatrio Eye Hospital of Athens, Athens, Greece; 2First Department of Ophthalmology, Medical School of Athens University...

Full description

Bibliographic Details
Main Authors: Dimitrios A Karagiannis, Ioannis D Ladas, Efstratios Parikakis, et al.
Format: Article
Language:English
Published: Dove Medical Press 2009-11-01
Series:Clinical Interventions in Aging
Subjects:
Age related macular degeneration
Bevacizumab
Ranimizumab
subretinal haemorrhage
Online Access:https://www.dovepress.com/changing-from-bevacizumab-to-ranibizumab-in-age-related-macular-degene-peer-reviewed-article-CIA

Internet

https://www.dovepress.com/changing-from-bevacizumab-to-ranibizumab-in-age-related-macular-degene-peer-reviewed-article-CIA

Similar Items